milrinone has been researched along with flosequinan in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hague, NL; Hunneyball, IM; Loh, E; Morgan, JP; Perreault, CL; Sim, MF | 1 |
| Maitland, LA; Morgan, KG; Resnick, MS | 1 |
| Falotico, R; Haertlein, BJ; Lakas-Weiss, CS; Salata, JJ; Tobia, AJ | 1 |
| Britton, LW; Ferraris, VA; Kiser, LM; Sim, MF; Wallace, AM; Weishaar, RE | 1 |
| Dickinson, K; Foster, GA; Frodsham, G; Jones, RB | 1 |
| Britton, LW; Ferraris, VA; Kirker, ML; Sim, MF; Wallace, AM; Weishaar, RE | 1 |
| Miao, L; Morgan, JP; Perreault, CL; Travers, KE | 1 |
7 other study(ies) available for milrinone and flosequinan
| Article | Year |
|---|---|
Differential inotropic effects of flosequinan in ventricular muscle from normal ferrets versus patients with end-stage heart failure.
Topics: Animals; Calcium; Colforsin; Dose-Response Relationship, Drug; Ferrets; Heart Failure; Heart Ventricles; Humans; In Vitro Techniques; Male; Milrinone; Myocardial Contraction; Pyridones; Quinolines; Quinolones; Stimulation, Chemical; Vasodilator Agents | 1992 |
Flosequinan, a vasodilator with a novel mechanism of action.
Topics: Aequorin; Animals; Aorta, Thoracic; Calcium; Ferrets; In Vitro Techniques; Male; Milrinone; Muscle Contraction; Nitroprusside; Phenylephrine; Potassium; Pyridones; Quinolines; Vasodilator Agents | 1991 |
Positive inotropic and hemodynamic properties of flosequinan, a new vasodilator, and a sulfone metabolite.
Topics: Amrinone; Anesthesia; Animals; Ferrets; Heart Failure; Heart Rate; Hemodynamics; In Vitro Techniques; Infusions, Intravenous; Male; Milrinone; Myocardial Contraction; Papillary Muscles; Pentobarbital; Pyridones; Quinolines; Vasodilator Agents | 1989 |
Assessment of flosequinan's direct effect on human arterial, venous, and cardiac muscle: comparison with other classes of agents used to treat heart failure.
Topics: Captopril; Diltiazem; Heart Failure; Humans; In Vitro Techniques; Milrinone; Muscle Contraction; Muscle, Smooth, Vascular; Myocardial Contraction; Ouabain; Pyridones; Quinolines; Quinolones; Vasodilator Agents | 1994 |
Effect of flosequinan on ischaemia-induced arrhythmias and on ventricular cyclic nucleotide content in the anaesthetized rat.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Anesthesia; Animals; Arrhythmias, Cardiac; Blood Pressure; Colforsin; Coronary Vessels; Cyclic AMP; Cyclic GMP; Enzyme Activation; Isoproterenol; Male; Milrinone; Myocardial Ischemia; Myocardium; Phosphodiesterase Inhibitors; Pyridones; Quinolines; Rats; Rats, Wistar; Vasodilator Agents | 1993 |
Relationship between inotropic activity and phosphodiesterase inhibition for flosequinan and milrinone.
Topics: Humans; In Vitro Techniques; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyridones; Quinolines; Quinolones; Vasodilation | 1993 |
Mechanisms of positive inotropic action of flosequinan, hydralazine, and milrinone on mammalian myocardium.
Topics: Aequorin; Animals; Calcium Channel Blockers; Cardiotonic Agents; Carrier Proteins; Enzyme Inhibitors; Ferrets; Heart; Hydralazine; In Vitro Techniques; Male; Milrinone; Myocardial Contraction; Ouabain; Procaine; Pyridones; Quinolines; Sodium-Calcium Exchanger; Sodium-Hydrogen Exchangers; Sodium-Potassium-Exchanging ATPase; Stimulation, Chemical; Tetrodotoxin; Vasodilator Agents; Verapamil | 1997 |